Steffan Nawrocki, PhD

Publications

2023

Jones, T. M., C. M. Espitia, J. Chipollini, B. R. Lee, J. A. Wertheim, J. S. Carew, and S. T. Nawrocki, "Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity.", Cancer Res Commun, vol. 3, issue 2, pp. 245-257, 2023 Feb. PMCID: PMC9973416 

Garcia, K., T. Jones, C. Espitia, J. Chipollini, B. Lee, J. Wertheim, J. Carew, and S. Nawrocki, "MP28-15 A NEW STRATEGY TO ENHANCE CISPLATIN EFFICACY WHILE REDUCING NEPHROTOXICITY THROUGH TARGETED NEDDYLATION INHIBITION", Journal of Urology, vol. 209, issue 4 supplement, 04/2023.

Bao, C., S. Liang, Y. Han, Z. Yang, S. Liu, Y. Sun, S. Zheng, Y. Li, T. Wang, Y. Gu, et al., "The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension.", Hypertension, vol. 80, issue 1, pp. 70-83, 2023 Jan. PMID: 36345832

2022

Jones, T. M., C. M. Espitia, A. Ooi, J. E. Bauman, J. S. Carew, and S. T. Nawrocki, "Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism.", Cell Death Dis, vol. 13, issue 4, pp. 350, 2022 Apr 15. PMCID: PMC9012827  PMID: 35428778